South Korea · Delayed Price · Currency is KRW Biodyne Statistics
Total Valuation
Biodyne has a market cap or net worth of KRW 243.77 billion. The enterprise value is 228.56 billion.
| Market Cap | 243.77B |
| Enterprise Value | 228.56B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biodyne has 29.48 million shares outstanding.
| Current Share Class | 29.48M |
| Shares Outstanding | 29.48M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.66% |
| Owned by Insiders (%) | 42.62% |
| Owned by Institutions (%) | 0.44% |
| Float | 16.91M |
Valuation Ratios
The trailing PE ratio is 169.76 and the forward PE ratio is 55.78.
| PE Ratio | 169.76 |
| Forward PE | 55.78 |
| PS Ratio | 34.93 |
| PB Ratio | 5.50 |
| P/TBV Ratio | 6.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 20,009.24 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 158.51 |
| EV / Sales | 32.75 |
| EV / EBITDA | 99.46 |
| EV / EBIT | 216.28 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 39.77, with a Debt / Equity ratio of 0.00.
| Current Ratio | 39.77 |
| Quick Ratio | 38.18 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | -0.00 |
| Interest Coverage | 6,774.28 |
Financial Efficiency
Return on equity (ROE) is 3.30% and return on invested capital (ROIC) is 3.50%.
| Return on Equity (ROE) | 3.30% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 3.50% |
| Return on Capital Employed (ROCE) | 2.39% |
| Weighted Average Cost of Capital (WACC) | 10.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Biodyne has paid 83.01 million in taxes.
| Income Tax | 83.01M |
| Effective Tax Rate | 5.44% |
Stock Price Statistics
The stock price has decreased by -43.09% in the last 52 weeks. The beta is 1.05, so Biodyne's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -43.09% |
| 50-Day Moving Average | 9,773.60 |
| 200-Day Moving Average | 12,447.75 |
| Relative Strength Index (RSI) | 37.99 |
| Average Volume (20 Days) | 46,945 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biodyne had revenue of KRW 6.98 billion and earned 1.44 billion in profits. Earnings per share was 48.72.
| Revenue | 6.98B |
| Gross Profit | 4.50B |
| Operating Income | 1.06B |
| Pretax Income | 1.52B |
| Net Income | 1.44B |
| EBITDA | 2.30B |
| EBIT | 1.06B |
| Earnings Per Share (EPS) | 48.72 |
Balance Sheet
The company has 15.22 billion in cash and 8.67 million in debt, with a net cash position of 15.21 billion or 516.13 per share.
| Cash & Cash Equivalents | 15.22B |
| Total Debt | 8.67M |
| Net Cash | 15.21B |
| Net Cash Per Share | 516.13 |
| Equity (Book Value) | 44.30B |
| Book Value Per Share | 1,502.85 |
| Working Capital | 18.14B |
Cash Flow
In the last 12 months, operating cash flow was 12.18 million and capital expenditures -3.31 billion, giving a free cash flow of -3.30 billion.
| Operating Cash Flow | 12.18M |
| Capital Expenditures | -3.31B |
| Depreciation & Amortization | 1.24B |
| Net Borrowing | -9.44M |
| Free Cash Flow | -3.30B |
| FCF Per Share | -111.93 |
Margins
Gross margin is 64.45%, with operating and profit margins of 15.14% and 20.66%.
| Gross Margin | 64.45% |
| Operating Margin | 15.14% |
| Pretax Margin | 21.85% |
| Profit Margin | 20.66% |
| EBITDA Margin | 32.93% |
| EBIT Margin | 15.14% |
| FCF Margin | n/a |
Dividends & Yields
Biodyne does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.59% |
| FCF Yield | -1.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 28, 2024. It was a forward split with a ratio of 5.
| Last Split Date | Feb 28, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |